SCHEMBL23619486

SCHEMBL23619486

O=c1ccn([C@@H]2O[C@@H]3C(O)[C@]3(O)[C@H]2O)n2ccnc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22577499 0.73 MAPT (0.51) —
SCHEMBL22083019 0.66 CCNE1 (0.31) —
SCHEMBL24487759 0.65 — —
SCHEMBL22072387 0.61 L3MBTL1 (0.34) —
SCHEMBL22071866 0.59 L3MBTL1 (0.33) —
SCHEMBL22079611 0.57 L3MBTL1 (0.32) —
SCHEMBL22071857 0.57 L3MBTL1 (0.32) —
SCHEMBL22072412 0.57 L3MBTL1 (0.32) —
SCHEMBL22083748 0.56 HTR6 (0.30) —
SCHEMBL24487786 0.55 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210206796-A1 CYCLIC DI-NUCLEOTIDE COMPOUNDS AS STING AGONISTS MERCK SHARP & DOHME CORP. (US) 2021-07-08 — — US disclosed
Send feedback